These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 17237276)

  • 1. Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes.
    Yates MS; Tauchi M; Katsuoka F; Flanders KC; Liby KT; Honda T; Gribble GW; Johnson DA; Johnson JA; Burton NC; Guilarte TR; Yamamoto M; Sporn MB; Kensler TW
    Mol Cancer Ther; 2007 Jan; 6(1):154-62. PubMed ID: 17237276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole.
    Yates MS; Kwak MK; Egner PA; Groopman JD; Bodreddigari S; Sutter TR; Baumgartner KJ; Roebuck BD; Liby KT; Yore MM; Honda T; Gribble GW; Sporn MB; Kensler TW
    Cancer Res; 2006 Feb; 66(4):2488-94. PubMed ID: 16489057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling.
    Liby K; Hock T; Yore MM; Suh N; Place AE; Risingsong R; Williams CR; Royce DB; Honda T; Honda Y; Gribble GW; Hill-Kapturczak N; Agarwal A; Sporn MB
    Cancer Res; 2005 Jun; 65(11):4789-98. PubMed ID: 15930299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDDO-Im protects from acetaminophen hepatotoxicity through induction of Nrf2-dependent genes.
    Reisman SA; Buckley DB; Tanaka Y; Klaassen CD
    Toxicol Appl Pharmacol; 2009 Apr; 236(1):109-14. PubMed ID: 19371629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical evaluation of targeting the Nrf2 pathway by triterpenoids (CDDO-Im and CDDO-Me) for protection from LPS-induced inflammatory response and reactive oxygen species in human peripheral blood mononuclear cells and neutrophils.
    Thimmulappa RK; Fuchs RJ; Malhotra D; Scollick C; Traore K; Bream JH; Trush MA; Liby KT; Sporn MB; Kensler TW; Biswal S
    Antioxid Redox Signal; 2007 Nov; 9(11):1963-70. PubMed ID: 17822364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel synthetic pyridyl analogues of CDDO-Imidazolide are useful new tools in cancer prevention.
    Cao M; Onyango EO; Williams CR; Royce DB; Gribble GW; Sporn MB; Liby KT
    Pharmacol Res; 2015 Oct; 100():135-47. PubMed ID: 26238177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide.
    Shin S; Wakabayashi J; Yates MS; Wakabayashi N; Dolan PM; Aja S; Liby KT; Sporn MB; Yamamoto M; Kensler TW
    Eur J Pharmacol; 2009 Oct; 620(1-3):138-44. PubMed ID: 19698707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dimethyl fumarate and the oleanane triterpenoids, CDDO-imidazolide and CDDO-methyl ester, both activate the Nrf2 pathway but have opposite effects in the A/J model of lung carcinogenesis.
    To C; Ringelberg CS; Royce DB; Williams CR; Risingsong R; Sporn MB; Liby KT
    Carcinogenesis; 2015 Jul; 36(7):769-81. PubMed ID: 25939751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic triterpenoids attenuate cytotoxic retinal injury: cross-talk between Nrf2 and PI3K/AKT signaling through inhibition of the lipid phosphatase PTEN.
    Pitha-Rowe I; Liby K; Royce D; Sporn M
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5339-47. PubMed ID: 19494206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The triterpenoid CDDO-imidazolide confers potent protection against hyperoxic acute lung injury in mice.
    Reddy NM; Suryanaraya V; Yates MS; Kleeberger SR; Hassoun PM; Yamamoto M; Liby KT; Sporn MB; Kensler TW; Reddy SP
    Am J Respir Crit Care Med; 2009 Nov; 180(9):867-74. PubMed ID: 19679692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice.
    Yates MS; Tran QT; Dolan PM; Osburn WO; Shin S; McCulloch CC; Silkworth JB; Taguchi K; Yamamoto M; Williams CR; Liby KT; Sporn MB; Sutter TR; Kensler TW
    Carcinogenesis; 2009 Jun; 30(6):1024-31. PubMed ID: 19386581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The triterpenoid CDDO-imidazolide ameliorates mouse liver ischemia-reperfusion injury through activating the Nrf2/HO-1 pathway enhanced autophagy.
    Xu D; Chen L; Chen X; Wen Y; Yu C; Yao J; Wu H; Wang X; Xia Q; Kong X
    Cell Death Dis; 2017 Aug; 8(8):e2983. PubMed ID: 28796242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDDO-9,11-dihydro-trifluoroethyl amide (CDDO-dhTFEA) induces hepatic cytoprotective genes and increases bile flow in rats.
    Reisman SA; Ward KW; Klaassen CD; Meyer CJ
    Xenobiotica; 2013 Jul; 43(7):571-8. PubMed ID: 23244591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics of Chemically Distinct Classes of Keap1-Nrf2 Activators Identify Common and Unique Gene, Protein, and Pathway Responses In Vivo.
    Wible RS; Tran QT; Fathima S; Sutter CH; Kensler TW; Sutter TR
    Mol Pharmacol; 2018 Apr; 93(4):297-308. PubMed ID: 29367259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic or pharmacologic amplification of nrf2 signaling inhibits acute inflammatory liver injury in mice.
    Osburn WO; Yates MS; Dolan PD; Chen S; Liby KT; Sporn MB; Taguchi K; Yamamoto M; Kensler TW
    Toxicol Sci; 2008 Jul; 104(1):218-27. PubMed ID: 18417483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Point Mutation at C151 of
    Gatbonton-Schwager T; Yagishita Y; Joshi T; Wakabayashi N; Srinivasan H; Suzuki T; Yamamoto M; Kensler TW
    Mol Pharmacol; 2023 Aug; 104(2):51-61. PubMed ID: 37188495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The synthetic triterpenoid CDDO-Imidazolide suppresses experimental liver metastasis.
    Townson JL; Macdonald IC; Liby KT; Mackenzie L; Dales DW; Hedley BD; Foster PJ; Sporn MB; Chambers AF
    Clin Exp Metastasis; 2011 Mar; 28(3):309-17. PubMed ID: 21234655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic triterpenoids inhibit growth and induce apoptosis in human glioblastoma and neuroblastoma cells through inhibition of prosurvival Akt, NF-kappaB and Notch1 signaling.
    Gao X; Deeb D; Jiang H; Liu Y; Dulchavsky SA; Gautam SC
    J Neurooncol; 2007 Sep; 84(2):147-57. PubMed ID: 17361329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoprotection of human endothelial cells against oxidative stress by 1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole (CDDO-Im): application of systems biology to understand the mechanism of action.
    Wang X; Bynum JA; Stavchansky S; Bowman PD
    Eur J Pharmacol; 2014 Jul; 734():122-31. PubMed ID: 24703885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and quantification of the basal and inducible Nrf2-dependent proteomes in mouse liver: biochemical, pharmacological and toxicological implications.
    Walsh J; Jenkins RE; Wong M; Olayanju A; Powell H; Copple I; O'Neill PM; Goldring CE; Kitteringham NR; Park BK
    J Proteomics; 2014 Aug; 108(100):171-87. PubMed ID: 24859727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.